CBD Life Sciences Inc. (CBDL) Looking to Acquire a Cannabis Growth License in North Las Vegas
CBD Life Sciences (CBDL) has announced plans to acquire a cannabis growth license in North Las Vegas, valued at $10 million. The acquisition is projected to generate $5 million in gross revenue by 2025, positioning CBDL to expand in Nevada's cannabis market, expected to reach $1.3 billion by 2025.
The company aims to leverage North Las Vegas's strategic location near 40+ million annual tourists and key distribution channels. CBDL plans to vertically integrate operations through this expansion, enabling white-label partnerships, direct-to-consumer sales, and new product development. The company reports a 1,405.46% revenue increase since February 2024, demonstrating strong growth momentum.
CBD Life Sciences (CBDL) ha annunciato piani per acquisire una licenza per la coltivazione di cannabis a North Las Vegas, del valore di $10 milioni. Si prevede che l'acquisizione genererà $5 milioni di fatturato lordo entro il 2025, posizionando CBDL per espandersi nel mercato della cannabis del Nevada, che si prevede raggiungerà $1,3 miliardi entro il 2025.
La compagnia punta a sfruttare la posizione strategica di North Las Vegas, vicino a oltre 40 milioni di turisti all'anno e ai principali canali di distribuzione. CBDL prevede di integrare verticalmente le proprie operazioni attraverso questa espansione, consentendo partnership a marchio bianco, vendite dirette al consumatore e sviluppo di nuovi prodotti. L'azienda riporta un incremento del fatturato del 1.405,46% dal febbraio 2024, dimostrando un forte slancio di crescita.
CBD Life Sciences (CBDL) ha anunciado planes para adquirir una licencia de cultivo de cannabis en North Las Vegas, valorada en $10 millones. Se proyecta que la adquisición genere $5 millones en ingresos brutos para 2025, posicionando a CBDL para expandirse en el mercado de cannabis de Nevada, que se espera alcance $1.3 mil millones para 2025.
La compañía busca aprovechar la ubicación estratégica de North Las Vegas, cerca de más de 40 millones de turistas anuales y canales de distribución clave. CBDL planea integrar verticalmente las operaciones a través de esta expansión, permitiendo asociaciones de marca blanca, ventas directas al consumidor y desarrollo de nuevos productos. La compañía informa un aumento del 1,405.46% en ingresos desde febrero de 2024, demostrando un fuerte impulso de crecimiento.
CBD 라이프 사이언스 (CBDL)는 $10백만의 가치가 있는 노스 라스베이거스에서 대마초 재배 면허를 인수할 계획을 발표했습니다. 이 인수는 2025년까지 총 수익 $5백만을 창출할 것으로 예상되며, CBDL이 2025년까지 $1.3 billion에 이를 것으로 예상되는 네바다의 대마초 시장에서 확장할 수 있는 위치에 놓이게 됩니다.
회사는 연간 4,000만 명 이상의 관광객과 주요 유통 경로 근처에 있는 노스 라스베이거스의 전략적 위치를 활용하는 것을 목표로 하고 있습니다. CBDL은 이번 확장을 통해 수직적으로 운영을 통합할 계획이며, 이를 통해 화이트 라벨 파트너십, 소비자 직접 판매 및 새로운 제품 개발을 가능하게 합니다. 이 회사는 2024년 2월 이후로 수익이 1,405.46% 증가했습니다, 이는 강력한 성장 모멘텀을 보여줍니다.
CBD Life Sciences (CBDL) a annoncé des plans pour acquérir une licence de croissance de cannabis à North Las Vegas, évaluée à 10 millions de dollars. L'acquisition devrait générer 5 millions de dollars de revenus bruts d'ici 2025, plaçant CBDL pour s'étendre sur le marché du cannabis du Nevada, qui devrait atteindre 1,3 milliard de dollars d'ici 2025.
La société vise à tirer parti de l'emplacement stratégique de North Las Vegas, près de plus de 40 millions de touristes annuels et de canaux de distribution clés. CBDL prévoit d'intégrer verticalement les opérations par le biais de cette expansion, permettant des partenariats en marque blanche, des ventes directes aux consommateurs et le développement de nouveaux produits. L'entreprise signale une augmentation de 1,405.46 % des revenus depuis février 2024, démontrant ainsi une forte dynamique de croissance.
CBD Life Sciences (CBDL) hat Pläne angekündigt, eine Lizenz zum Anbau von Cannabis in North Las Vegas zu erwerben, die mit $10 Millionen bewertet wird. Der Erwerb soll bis 2025 $5 Millionen Bruttoumsatz generieren und positioniert CBDL für eine Expansion im Glücksspielmarkt von Nevada, der bis 2025 voraussichtlich $1,3 Milliarden erreichen wird.
Das Unternehmen beabsichtigt, die strategische Lage von North Las Vegas mit über 40 Millionen jährlichen Touristen und wichtigen Vertriebskanälen zu nutzen. CBDL plant, operationale Abläufe durch diese Expansion vertikal zu integrieren, um Weißmarken-Partnerschaften, Direktvertrieb und die Entwicklung neuer Produkte zu ermöglichen. Das Unternehmen berichtet über einen Umsatzanstieg von 1,405.46% seit Februar 2024, was auf eine starke Wachstumsdynamik hinweist.
- Target acquisition valued at $10M with projected $5M gross revenue by 2025
- Strategic location near Las Vegas's 40+ million annual tourists
- 1,405.46% revenue increase since February 2024
- Vertical integration opportunities through white-label partnerships and direct sales
- Entry into Nevada's cannabis market projected to reach $1.3B by 2025
- Significant capital investment required for $10M acquisition
- Revenue projections are speculative and not guaranteed
- Entering highly competitive Nevada cannabis market
Target Acquisition Valued at
SCOTTSDALE, AZ / ACCESSWIRE / December 11, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leader in CBD innovation, announces its intent to acquire a cannabis growth license in North Las Vegas, a move that could serve as a transformative step in the company's evolution. With a target business value of
Expanding beyond its already successful CBD product portfolio, this acquisition will enable CBDL to enter the cannabis cultivation and distribution space, capitalizing on the robust demand for high-quality cannabis products in Nevada and across the nation. This strategic pivot is set to unlock significant revenue potential while solidifying the company's status as a dual-market powerhouse in both CBD and cannabis.
The Nevada Cannabis Market: A Strategic Opportunity
Nevada is one of the most dynamic cannabis markets in the United States, driven by strong consumer demand, progressive regulations, and a booming tourism industry. North Las Vegas, located within Clark County, offers a unique advantage for cannabis cultivation due to its proximity to Las Vegas' 40+ million annual tourists and access to key distribution channels. With legalization trends continuing to sweep the nation, Nevada's cannabis market remains a critical growth hub for companies like CBDL.
Securing a cannabis growth license in this region offers unparalleled potential. Cannabis cultivation facilities in Nevada have demonstrated the ability to generate annual revenues ranging from
Diversifying Revenue and Strengthening Market Position
The cannabis growth license acquisition aligns with CBDL's long-term strategy of diversification and growth. In addition to providing a new revenue channel, this venture allows the company to vertically integrate its operations, controlling production quality while reducing costs. Vertical integration is particularly advantageous in the cannabis industry, where consistency, compliance, and quality are key differentiators.
By producing cannabis in-house, CBDL gains greater control over the supply chain and opens doors to additional high-margin opportunities, including:
White-label partnerships with other cannabis brands.
Direct-to-consumer sales through dispensaries.
Product development leveraging CBDL's expertise in formulating premium CBD products.
This expansion also strengthens CBDL's ability to cater to diverse consumer preferences, from recreational cannabis users to medical patients seeking relief through high-quality cannabis products.
Revenue Projections That Excite
As part of this expansion, CBDL anticipates a substantial increase in its revenue trajectory. The company's current growth momentum, evidenced by a 1,
Additionally, the Nevada cannabis market benefits from one of the most business-friendly taxation systems in the country, providing further incentives for long-term profitability. Coupled with its flourishing tourism industry and expanding local customer base, this acquisition represents a near-perfect synergy between market opportunity and company capabilities.
Endless Possibilities for Growth and Innovation
The cannabis industry is evolving at an unprecedented pace, with significant advancements in cultivation technology, product innovation, and consumer awareness. By establishing a foothold in North Las Vegas, CBDL can leverage these trends to develop cutting-edge products that appeal to a wide range of consumers. The potential for partnerships with dispensaries, research institutions, and wellness companies further underscores the limitless growth opportunities this acquisition presents.
"This is not just another step for CBD Life Sciences Inc. - it's a leap toward redefining our company's future," said Lisa Nelson, President and CEO of CBDL. "With a cannabis growth license in North Las Vegas, we are positioned to accelerate our growth, diversify our portfolio, and deliver unmatched value to our shareholders."
Looking Ahead: A Bright Future for CBDL
CBDL's entrance into the cannabis cultivation market represents a monumental shift in its operational strategy, but it's only the beginning. As the company continues to explore expansion opportunities in Nevada and other high-growth regions, shareholders and investors can expect exciting updates in the months ahead.
The acquisition of this growth license is more than a business move - it's a testament to CBDL's commitment to innovation, growth, and shareholder value. With the cannabis and CBD markets projected to reach record-breaking revenues in the coming years, CBDL is positioning itself as a trailblazer in the wellness industry.
For more information, please visit CBD Life Sciences Inc.
About CBD Life Sciences Inc.
CBD Life Sciences Inc. (OTC:CBDL) is a leader in the CBD and wellness industries, specializing in premium CBD products and innovative solutions. With a proven track record of growth and a forward-thinking approach, CBDL continues to expand its presence in emerging markets, driving shareholder value and industry leadership.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information:
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
Related Images
|
SOURCE: CBD Life Sciences Inc.
View the original press release on accesswire.com
FAQ
What is the value of CBDL's planned cannabis license acquisition in North Las Vegas?
What is CBDL's projected revenue from the North Las Vegas cannabis license by 2025?
How much has CBDL's revenue increased since February 2024?
What is the projected size of Nevada's cannabis market by 2025?
What business opportunities will the cannabis license provide for CBDL?
